Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
admitted	O
with	O
febrile	O
neutrapenia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
___	O
PMHs	O
of	O
MDS-AML	O
transformation	O
(now	O
on	O
Mylotarg	O
C1D1	O
___	O
(s/p	O
left	O
nephrectomy	O
___,	O
Squamous	O
cell	O
Ca	O
(s/p	O
resection),	O
CAD	O
(1	O
vessel,	O
s/p	O
stent	O
___,	O
HTN,	O
Gout,	O
who	O
presented	O
from	O
outpatient	O
clinic	O
for	O
management	O
and	O
work-up	O
of	O
fever	O
and	O
neutropenia.	O
He	O
has	O
been	O
getting	O
regular	O
transfusions	O
for	O
his	O
cytopenias,	O
including	O
___	O
and	O
___.	O
In	O
the	O
evening	O
of	O
___	O
he	O
started	O
to	O
feel	O
chills	O
while	O
visiting	O
his	O
son,	O
so	O
went	O
home.	O
He	O
had	O
a	O
temperature	O
as	O
high	O
as	O
___,	O
for	O
which	O
he	O
took	O
Tylenol	O
and	O
defervesced.	O
He	O
did	O
not	O
call	O
or	O
present	O
to	O
the	O
ED	O
because	O
he	O
was	O
reassured	O
by	O
his	O
decreased	O
fever	O
and	O
wanted	O
to	O
sleep	O
in	O
his	O
bed,	O
despite	O
previous	O
instructions	O
to	O
call	O
with	O
fever.	O
He	O
then	O
presented	O
to	O
outpatient	O
clinic	O
for	O
transfusion,	O
where	O
he	O
was	O
noted	O
again	O
to	O
be	O
febrile	O
to	O
101.6F	O
and	O
cytopenic	O
(ANC	O
7,	O
210	O
blasts,	O
Hgb	O
9.0,	O
PLT	O
of	O
13.	O
Blood	O
cultures	O
were	O
drawn,	O
U/A	O
was	O
unremarkable,	O
and	O
CXR	O
was	O
also	O
unremarkable.	O
He	O
received	O
1g	O
vancomycin,	O
2g	O
cefepime,	O
IVF,	O
and	O
was	O
admitted.	O
Upon	O
interview	O
in	O
the	O
hospital,	O
he	O
denies	O
any	O
new	O
complaints,	O
and	O
feels	O
quite	O
good.	O
Denies	O
current	O
fever,	O
chills,	O
rigors,	O
diaphoresis,	O
sinus	O
pain	O
or	O
congestion,	O
vision	O
changes,	O
dyspnea,	O
cough,	O
abdominal	O
pain,	O
diarrhea,	O
lower	O
extremity	O
swelling,	O
dysuria	O
or	O
other	O
change	O
in	O
urinary	O
habits.	O
Past	O
Medical	O
History:	O
As	O
per	O
last	O
___	O
clinic	O
note:	O
"dx	O
MDS	O
___,	O
transformed	O
to	O
AML	O
___:	O
admitted	O
to	O
hospital	O
for	O
dyspnea	O
and	O
fatigue.	O
On	O
admission	O
found	O
to	O
be	O
pancytopenic	O
with	O
hgb	O
5.2,	O
plt	O
63,000,	O
WBC	O
3.4,	O
10%	O
blasts.	O
___	O
confirmed	O
MDS	O
with	O
hyperplasia	O
and	O
fibrosis	O
-	O
___:	O
Peripheral	O
blasts	O
of	O
22%	O
meeting	O
WHO	O
criteria	O
of	O
AML	O
STUDY	O
TREATMENT	O
HISTORY:	O
Started	O
MUC	O
protocol	O
___	O
-	O
___	O
Cycle	O
1	O
treatment	O
plan:	O
Cycle	O
1	O
Plan:	O
GO-203-2C	O
18mg/m2	O
IV	O
on	O
days	O
___	O
and	O
___	O
of	O
28	O
day	O
cycle.	O
Decitabine	O
20mg/m2	O
IV	O
on	O
days	O
___	O
of	O
28	O
day	O
cycle.	O
Last	O
dose	O
-	O
___	O
Cycle	O
7	O
treatment	O
plan:	O
GO-203-2C	O
18	O
mg/m2	O
IV	O
on	O
days	O
___	O
and	O
___	O
of	O
28	O
day	O
cycle.	O
Decitabine	O
20	O
mg/m2	O
IV	O
on	O
days	O
___	O
of	O
28	O
day	O
cycle.	O
-___	O
C1D1	O
Mylotarg	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
MDS->AML	O
-	O
Stage	O
T1	O
renal	O
cell	O
carcinoma,	O
status	O
post	O
left	O
radical	O
nephrectomy	O
at	O
___	O
in	O
___	O
-	O
Squamous	O
cell	O
skin	O
cancer,	O
status	O
post	O
resection	O
-	O
Elevated	O
PSA	O
followed	O
by	O
Urology,	O
felt	O
to	O
be	O
due	O
to	O
benign	O
prostatic	O
hypertrophy	O
-	O
Adenomatous	O
colon	O
polyps	O
on	O
colonoscopy	O
in	O
___,	O
status	O
post	O
resection.	O
-	O
One	O
vessel	O
CAD	O
status	O
post	O
bare	O
metal	O
stent	O
to	O
mid	O
LAD	O
in	O
___	O
-	O
Upper	B-Upper_gastrointestinal_haemorrhage
GI	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
about	O
___	O
years	O
ago,	O
status	O
post	O
endoscopic	O
intervention;	O
per	O
patient	O
report	O
was	O
attributed	O
to	O
aspirin,	O
no	O
recurrence	O
since	O
starting	O
PPI	O
-	O
Hypertension	O
-	O
Dyslipidemia	O
-	O
CKD	O
stage	O
III	O
-	O
Gout	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
at	O
___	O
of	O
heart	O
disease.	O
Mother	O
died	O
at	O
age	O
___	O
of	O
old	O
age.	O
Brother,	O
coronary	O
artery	O
disease	O
requiring	O
CABG,	O
question	O
history	O
of	O
atrial	O
fibrillation.	O
Three	O
adult	O
children,	O
all	O
healthy.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
Vitals:	O
98.8	O
128/68	O
73	O
18	O
98%	O
RA	O
Gen:	O
Pleasant,	O
calm	O
and	O
conversive	O
HEENT:	O
No	O
conjunctival	O
pallor.	O
No	O
icterus.	O
MMM.	O
OP	O
clear.	O
NECK:	O
no	O
appreciable	O
JVP	O
LYMPH:	O
No	O
cervical	O
or	O
supraclav	O
LAD	O
CV:	O
Normocardic,	O
regular.	O
Normal	O
S1,S2.	O
No	O
m/r/g	O
LUNGS:	O
CTAB.	O
No	O
wheezes,	O
rales,	O
or	O
rhonchi.	O
Breathing	O
without	O
distress	O
ABD:	O
NABS.	O
Soft,	O
NT,	O
ND.	O
EXT:	O
WWP.	O
No	O
___	O
edema.	O
SKIN:	O
No	O
rashes/lesions,	O
petechiae/purpura	O
ecchymoses.	O
NEURO:	O
A&Ox3.	B-Delirium
LINES:	O
R	O
chest	O
port	O
with	O
dried	O
blood	O
and	O
mild	O
erythema	O
(unclear	O
if	O
chronic,	O
but	O
not	O
warm)	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
VS:	O
TC	O
98	O
___	O
97-99%RA	O
I/O:	O
___	O
BM	O
x1	O
GEN:	O
Pleasant,	O
calm	O
and	O
conversive	O
HEENT:	O
No	O
conjunctival	O
pallor.	O
No	O
icterus.	O
MMM.	O
OP	O
clear.	O
+	O
ecchymosis	O
on	O
nasal	O
bridge	O
and	O
right	O
buccal	O
area.	O
NECK:	O
No	O
appreciable	O
JVP	O
LYMPH:	O
No	O
cervical	O
or	O
supraclav	O
LAD	O
CV:	O
Normocardic,	O
regular.	O
Normal	O
S1,S2.	O
No	O
m/r/g	O
LUNGS:	O
CTAB.	O
No	O
wheezes,	O
rales,	O
or	O
rhonchi.	O
ABD:	O
NABS.	O
Soft,	O
rounded	O
but	O
NT/ND.	O
EXT:	O
WWP.	O
No	O
___	O
edema	O
or	O
tremors.	O
SKIN:	O
No	O
rashes/lesions,	O
petechiae/purpura	O
ecchymoses.	O
NEURO:	O
A&Ox3,	B-Delirium
grossly	O
non-focal.	O
LINES:	O
R	O
chest	O
port	O
with	O
dried	O
blood,	O
no	O
discharge,	O
swelling	O
or	O
tenderness	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
===============	O
___	O
08:30AM	O
BLOOD	O
WBC-0.6*	O
RBC-2.42*	O
Hgb-7.7*	O
Hct-22.3*	O
MCV-92	O
MCH-31.8	O
MCHC-34.5	O
RDW-15.3	O
RDWSD-51.6*	O
Plt	O
Ct-20*	O
___	O
08:30AM	O
BLOOD	O
Neuts-3*	O
Bands-0	O
Lymphs-65*	O
Monos-2*	O
Eos-0	O
Baso-0	O
___	O
Myelos-0	O
Blasts-30*	O
NRBC-1*	O
AbsNeut-0.02*	O
AbsLymp-0.39*	O
AbsMono-0.01*	O
AbsEos-0.00*	O
AbsBaso-0.00*	O
___	O
08:30AM	O
BLOOD	O
UreaN-30*	O
Creat-1.1	O
DISCHARGE	O
LABS:	O
===============	O
___	O
12:00AM	O
BLOOD	O
WBC-1.1*	O
RBC-2.37*	O
Hgb-7.4*	O
Hct-20.7*	O
MCV-87	O
MCH-31.2	O
MCHC-35.7	O
RDW-15.6*	O
RDWSD-49.6*	O
Plt	O
Ct-8*	O
___	O
12:00AM	O
BLOOD	O
Neuts-3*	O
Bands-0	O
Lymphs-61*	O
Monos-1*	O
Eos-0	O
Baso-0	O
___	O
Metas-1*	O
Myelos-0	O
Blasts-34*	O
AbsNeut-0.03*	O
AbsLymp-0.67*	O
AbsMono-0.01*	O
AbsEos-0.00*	O
AbsBaso-0.00*	O
___	O
12:00AM	O
BLOOD	O
Hypochr-NORMAL	O
Anisocy-NORMAL	O
Poiklo-NORMAL	O
Macrocy-NORMAL	O
Microcy-NORMAL	O
Polychr-NORMAL	O
___	O
07:05AM	O
BLOOD	O
Plt	O
Ct-13*#	O
___	O
12:00AM	O
BLOOD	O
Glucose-153*	O
UreaN-32*	O
Creat-1.1	O
Na-136	O
K-4.5	O
Cl-99	O
HCO3-23	O
AnGap-14	O
___	O
12:00AM	O
BLOOD	O
ALT-34	O
AST-41*	O
LD(LDH)-727*	O
AlkPhos-142*	O
TotBili-0.4	O
___	O
12:00AM	O
BLOOD	O
Albumin-2.9*	O
Calcium-8.4	O
Phos-3.5	O
Mg-2.2	O
IMAGING:	O
========	O
CHEST	O
CT	O
___	O
IMPRESSION:	O
1.	O
No	O
focal	O
consolidation	O
to	O
suggest	O
pneumonia.	B-Lower_respiratory_tract_infection
2.	O
Enlarging	O
9	O
mm	O
perifissural	O
solid	O
pulmonary	O
nodule	O
in	O
the	O
medial	O
pleural	O
based	O
aspect	O
of	O
the	O
right	O
lower	O
lobe	O
compared	O
to	O
___.	O
This	O
is	O
concerning	O
for	O
a	O
metastatic	O
disease	O
in	O
the	O
setting	O
of	O
known	O
renal	O
cancer.	O
PET-CT	O
is	O
recommended	O
for	O
further	O
evaluation.	O
CT	O
A/P	O
___	O
IMPRESSION:	O
Within	O
the	O
limits	O
of	O
a	O
noncontrast	O
study,	O
there	O
is	O
no	O
evidence	O
of	O
colitis	O
or	O
intra-abdominal	O
abscess.	O
CXR	O
PA/LATERAL	O
___:	O
IMPRESSION:	O
Tip	O
of	O
Port-A-Cath	O
in	O
cavoatrial	O
juncture.	O
MICRO:	O
======	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-PENDING	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-PENDING	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-FINAL	O
INPATIENT	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-FINAL	O
INPATIENT	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-FINAL	O
INPATIENT	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-FINAL	O
INPATIENT	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-FINAL	O
INPATIENT	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-FINAL	O
INPATIENT	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-FINAL	O
INPATIENT	O
___	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine-FINAL	O
{ESCHERICHIA	O
COLI};	O
Anaerobic	O
Bottle	O
Gram	O
Stain-FINAL;	O
Aerobic	O
Bottle	O
Gram	O
Stain-FINAL	O
Brief	O
Hospital	O
Course:	O
ACUTE	O
ISSUES:	O
===============	O
#Febrile	O
neutropenia:	O
#E	O
coli	O
Bacteremia:	O
source	O
likely	O
bowel	O
translocation	O
in	O
setting	O
of	O
severe	O
neutropenia	O
although	O
no	O
evidence	O
of	O
acute	O
intra-abdominal	O
sources	O
per	O
evaluation.	O
There	O
was	O
no	O
inconsistency	O
in	O
bowel	O
habits	O
per	O
patient.	O
No	O
BRBPR.	B-Lower_gastrointestinal_haemorrhage
Empirically	O
started	O
on	O
vancomycin	O
and	O
cefepime	O
on	O
___	O
but	O
changed	O
to	O
meropenem	O
___	O
with	O
persistent	O
fever	O
spikes.	O
Bacteremia	O
unlikely	O
to	O
be	O
causing	O
fevers	O
at	O
this	O
point	O
as	O
on	O
sensitive	O
ABX.	O
Discontinued	O
vancomycin	O
on	O
___	O
as	O
may	O
be	O
contributing	O
to	O
fever	O
per	O
ID	O
and	O
no	O
evidence	O
of	O
MRSA	O
infection.	O
He	O
has	O
evidence	O
of	O
a	O
new	O
RUL	O
___	O
lung	O
nodule	O
on	O
CT	O
chest	O
___.	O
Per	O
ID,	O
does	O
not	O
necessitate	O
change	O
in	O
fungal	O
therapy	O
(patient	O
has	O
been	O
on	O
voriconazole	O
since	O
___	O
for	O
positive	O
b-d-glucan).	O
Voriconazole	O
trough	O
on	O
___	O
was	O
3.5.	O
De-escalated	O
to	O
ciprofloxacin	O
on	O
___	O
as	O
pansensitive	O
plus	O
have	O
had	O
negative	O
blood	O
cultures	O
since	O
___	O
and	O
has	O
been	O
afebrile	O
>	O
72	O
hours.	O
Will	O
need	O
a	O
2	O
week	O
course	O
per	O
ID	O
from	O
day	O
he	O
cleared	O
his	O
bacteremia	O
(___)	O
but	O
this	O
could	O
be	O
continued	O
for	O
some	O
time	O
since	O
he	O
does	O
not	O
have	O
counts.	O
#MDS->AML	O
transformation	O
(now	O
on	O
Mylotarg:	O
___	O
C1D1,	O
D4,	O
D7	O
of	O
Mylotarg.	O
He	O
is	O
currently	O
D+22	O
of	O
his	O
regimen	O
today.	O
-Continue	O
acyclovir/voriconazole	O
-Currently	O
on	O
PJP/PCP	O
prophylaxis,	O
consider	O
since	O
remains	O
on	O
low	O
steroids	O
-Daily	O
CBC/Diff	O
-Transfuse	O
for	O
Hgb<7	O
or	O
plt	O
<10	O
-He	O
received	O
platelets	O
transfusion	O
on	O
___,	O
8---13	O
#Pancytopenia:	O
likely	O
secondary	O
to	O
his	O
underlying	O
AML	O
and/or	O
recent	O
chemotherapy,	O
continue	O
with	O
infectious	O
ppx	O
as	O
above	O
#HTN:	O
resumed	O
atenolol	O
on	O
___	O
as	O
HTN	O
was	O
exacerbation,	O
continue	O
to	O
monitor	O
outpatient.	O
CHRONIC/STABLE/RESOLVED	O
ISSUES:	O
===============================	O
___,	O
resolved:	O
Likely	O
pre-renal,	O
continue	O
to	O
monitor	O
outpatient.	O
Cr	O
1.1	O
today	O
Received	O
1L	O
NS	O
prior	O
to	O
discharge.	O
#Joint	O
pains/?	O
pseudogout	O
vs.	O
muscular	O
injury:	O
Has	O
long	O
history	O
of	O
gout	O
with	O
prior	O
increased	O
pain	O
in	O
shoulders.	O
MRI	O
showed	O
rotator	O
cuff	O
injury.	O
He	O
remains	O
on	O
MS	O
___	O
15	O
mg	O
once	O
per	O
day	O
but	O
has	O
been	O
complaining	O
of	O
increased	O
restless	O
on	O
his	O
legs	O
during	O
this	O
hospital	O
course.	O
Plan	O
to	O
switch	O
to	O
Oxycontin	O
10mg	O
BID	O
once	O
PA	O
approved.	O
Continues	O
on	O
Allopurinol.	O
Now	O
on	O
prednisone	O
7.5mg	O
daily	O
#CAD	O
(s/p	O
stent	O
___:	O
No	O
longer	O
on	O
ASA	O
given	O
low	O
platelets.	O
Continues	O
on	O
pravastatin	O
#ACCESS:	O
R	O
POC	O
#CODE:	O
Full	O
(confirmed)	O
#CONTACT:	O
Health	O
care	O
proxy	O
chosen:	O
Yes	O
Name	O
of	O
health	O
care	O
proxy:	O
___	O
Relationship:	O
daughter	O
Phone	O
number:	O
___	O
Date	O
on	O
form:	O
___	O
Proxy	O
form	O
in	O
chart:	O
___	O
Comments:	O
alternate:	O
___	O
___	O
#DISPO:	O
Discharged	O
___.	O
RTC	O
___	O
to	O
see	O
Dr.	O
___	O
for	O
likely	O
plts	O
transfusion	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acyclovir	O
400	O
mg	O
PO	O
Q12H	O
2.	O
Chlorhexidine	O
Gluconate	O
0.12%	O
Oral	O
Rinse	O
15	O
mL	O
ORAL	O
BID	O
3.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
constipation	O
4.	O
Hydrocortisone	O
Cream	O
1%	O
1	O
Appl	O
TP	O
BID:PRN	O
irritation	O
at	O
port	O
site	O
___	O
tegaderm	O
5.	O
Lansoprazole	O
Oral	O
Disintegrating	O
Tab	O
15	O
mg	O
Other	O
DAILY	O
6.	O
Morphine	O
SR	O
(MS	O
___	O
15	O
mg	O
PO	O
QHS	O
7.	O
Pravastatin	O
10	O
mg	O
PO	O
QPM	O
8.	O
PredniSONE	O
7.5	O
mg	O
PO	O
DAILY	O
9.	O
Voriconazole	O
200	O
mg	O
PO	O
Q12H	O
10.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
11.	O
Atenolol	O
25	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Ciprofloxacin	O
HCl	O
500	O
mg	O
PO	O
Q12H	O
2.	O
OxyCODONE	O
SR	O
(OxyconTIN)	O
10	O
mg	O
PO	O
Q12H	O
ONCE	O
YOUR	O
INSURANCE	O
APPROVAL	O
GOES	O
THROUGH,	O
YOU	O
CAN	O
START	O
OXYCONTIN	O
ONLY	O
AND	O
STOP	O
MS	O
CONTIN	O
3.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
4.	O
Acyclovir	O
400	O
mg	O
PO	O
Q12H	O
5.	O
Allopurinol	O
___	O
mg	O
PO	O
DAILY	O
6.	O
Atenolol	O
25	O
mg	O
PO	O
DAILY	O
7.	O
Chlorhexidine	O
Gluconate	O
0.12%	O
Oral	O
Rinse	O
15	O
mL	O
ORAL	O
BID	O
8.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
constipation	B-Constipation
9.	O
Hydrocortisone	O
Cream	O
1%	O
1	O
Appl	O
TP	O
BID:PRN	O
irritation	O
at	O
port	O
site	O
___	O
tegaderm	O
10.	O
Lansoprazole	O
Oral	O
Disintegrating	O
Tab	O
15	O
mg	O
Other	O
DAILY	O
11.	O
Morphine	O
SR	O
(MS	O
___	O
15	O
mg	O
PO	O
QHS	O
CONTINUE	O
UNTIL	O
YOUR	O
INSURANCE	O
APPROVAL	O
GOES	O
THROUGH	O
FOR	O
OXYCONTIN,	O
THEN	O
DISCONTINUE	O
12.	O
Pravastatin	O
10	O
mg	O
PO	O
QPM	O
13.	O
PredniSONE	O
7.5	O
mg	O
PO	O
DAILY	O
14.	O
Voriconazole	O
200	O
mg	O
PO	O
Q12H	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSIS:	O
=================	O
#E	O
Coli	O
Bacteremia	O
#Febrile	O
Neutrapenia	O
#AML	O
SECONDARY	O
DIAGNOSIS:	O
====================	O
#Hypertension	O
#Gout	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Mr.	O
___,	O
You	O
were	O
admitted	O
due	O
to	O
fever	O
when	O
your	O
blood	O
counts	O
were	O
low.	O
You	O
were	O
found	O
to	O
have	O
a	O
blood	O
infection	O
which	O
improved	O
with	O
IV	O
antibiotics.	O
You	O
will	O
continue	O
oral	O
antibiotics	O
(ciprofloxacin)	O
at	O
home	O
until	O
you	O
are	O
advised	O
to	O
discontinue.	O
You	O
will	O
follow	O
up	O
in	O
the	O
clinic	O
to	O
see	O
Dr.	O
___	O
as	O
stated	O
below.	O
Please	O
do	O
not	O
hesitate	O
to	O
call	O
in	O
the	O
meantime	O
with	O
any	O
questions	O
or	O
concerns.	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you.	O
Followup	O
Instructions:	O
___	O

